LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Serwin, Natalia Maria"
  2. AU="La Rosa, Stefano"
  3. AU="Yin-Yin Xie"
  4. AU=White David P
  5. AU="Maria Teresa Viadero"
  6. AU="Wingeter, Márcia A"
  7. AU="Stein, Joshua D"
  8. AU="De Vecchis, Liana"
  9. AU="Chapman, Janet"
  10. AU="Umlai, Umm-Kulthum Ismail"
  11. AU="Reddi, Jyoti M"
  12. AU=Zeissig Sebastian
  13. AU="Valentini, Mariaconsuelo"

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Biomarkers of the Complement System Activation (C3a, C5a, sC5b-9) in Serum of Patients before and after Liver Transplantation.

    Budkowska, Marta / Ostrycharz, Ewa / Serwin, Natalia Maria / Nazarewski, Łukasz / Cecerska-Heryć, Elżbieta / Poręcka, Marta / Rykowski, Paweł / Pietrzak, Radosław / Zieniewicz, Krzysztof / Siennicka, Aldona / Hukowska-Szematowicz, Beata / Dołęgowska, Barbara

    Biomedicines

    2023  Volume 11, Issue 7

    Abstract: The liver has a huge impact on the functioning of our body and the preservation of homeostasis. It is exposed to many serious diseases, which may lead to the chronic failure of this organ, which is becoming a global health problem today. Currently, the ... ...

    Abstract The liver has a huge impact on the functioning of our body and the preservation of homeostasis. It is exposed to many serious diseases, which may lead to the chronic failure of this organ, which is becoming a global health problem today. Currently, the final form of treatment in patients with end-stage (acute and chronic) organ failure is transplantation. The proper function of transplanted organs depends on many cellular processes and immune and individual factors. An enormous role in the process of acceptance or rejection of a transplanted organ is attributed to, among others, the activation of the complement system. The aim of this study was the evaluation of the concentration of selected biomarkers' complement system activation (C3a, C5a, and sC5b-9 (terminal complement complex)) in the serum of patients before and after liver transplantation (24 h, two weeks). The study was conducted on a group of 100 patients undergoing liver transplantation. There were no complications during surgery and no transplant rejection in any of the patients. All patients were discharged home 2-3 weeks after the surgery. The levels of all analyzed components of the complement system were measured using the ELISA method. Additionally, the correlations of the basic laboratory parameters-C-reactive protein (CRP), hemoglobin (Hb), total bilirubin, alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transpeptidase (GGTP), and albumin-with the parameters of the complement system (C3a, C5a, and sC5b-9) were determined. In our study, changes in the concentrations of all examined complement system components before and after liver transplantation were observed, with the lowest values before liver transplantation and the highest concentration two weeks after. The direct increase in components of the complement system (C3a, C5a, and sC5b-9) 24 h after transplantation likely affects liver damage after ischemia-reperfusion injury (IRI), while their increase two weeks after transplantation may contribute to transplant tolerance. Increasingly, attention is being paid to the role of C3a and CRP as biomarkers of damage and failure of various organs. From the point of view of liver transplantation, the most interesting correlation in our own research was found exactly between CRP and C3a, 24 h after the transplantation. This study shows that changes in complement activation biomarkers and the correlation with CRP in blood could be a prognostic signature of liver allograft survival or rejection.
    Language English
    Publishing date 2023-07-23
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2720867-9
    ISSN 2227-9059
    ISSN 2227-9059
    DOI 10.3390/biomedicines11072070
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Elevated Levels of Renalase, the β-NAD(P)H Isomerase, Can Be Used as Risk Factors of Major Adverse Cardiovascular Events and All-Cause Death in Patients with Chronic Kidney Disease.

    Knop, Wojciech / Serwin, Natalia Maria / Cecerska-Heryć, Elżbieta / Grygorcewicz, Bartłomiej / Dołęgowska, Barbara / Gomółka, Aleksandra / Wiśniewska, Magda / Ciechanowski, Kazimierz

    Biomolecules

    2021  Volume 11, Issue 10

    Abstract: Background: Renalase is an enzyme and a cytokine involved in cell survival. Since its discovery, associations between it and both cardiovascular and kidney disease have been noted. Recognizing this, we conducted a study in which we followed patients ... ...

    Abstract Background: Renalase is an enzyme and a cytokine involved in cell survival. Since its discovery, associations between it and both cardiovascular and kidney disease have been noted. Recognizing this, we conducted a study in which we followed patients with chronic kidney disease.
    Material and methods: The study involved 90 CKD patients with varying stages of the disease and 30 healthy controls. Renalase was measured with an ELISA kit, and patients were followed-up after a median of 18 months. During the follow-up, we asked about the occurrence of MACE, all-cause mortality and the need for dialysis initiation.
    Results: In CKD subgroups, RNSL correlated with all-cause death only in the HD group (Rs = 0.49,
    Conclusions: Elevated renalase levels can be used as a risk factor of MACE in patients with CKD, but its long-term utility needs further research. High renalase levels are a risk factor of death among CKD patients. In HD patients, all deaths were observed among patients with >30 μg/mL; this level could be used as a "red flag" marker in future studies.
    MeSH term(s) Adult ; Aged ; Cardiovascular Diseases/blood ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/mortality ; Cardiovascular Diseases/pathology ; Cause of Death ; Female ; Heart Disease Risk Factors ; Humans ; Male ; Middle Aged ; Monoamine Oxidase/blood ; Renal Insufficiency, Chronic/blood ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/mortality ; Renal Insufficiency, Chronic/pathology
    Chemical Substances Monoamine Oxidase (EC 1.4.3.4) ; renalase (EC 1.4.3.4.)
    Language English
    Publishing date 2021-10-14
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2701262-1
    ISSN 2218-273X ; 2218-273X
    ISSN (online) 2218-273X
    ISSN 2218-273X
    DOI 10.3390/biom11101514
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top